Bill & Melinda Gates Foundation Cure Vac N.V. Transaction History
Bill & Melinda Gates Foundation
- $43.5 Million
- Q3 2024
A detailed history of Bill & Melinda Gates Foundation transactions in Cure Vac N.V. stock. As of the latest transaction made, Bill & Melinda Gates Foundation holds 1,568,866 shares of CVAC stock, worth $3.91 Million. This represents 10.6% of its overall portfolio holdings.
Number of Shares
1,568,866
Previous 1,597,637
1.8%
Holding current value
$3.91 Million
Previous $5.43 Million
15.08%
% of portfolio
10.6%
Previous 13.5%
Shares
5 transactions
Others Institutions Holding CVAC
# of Institutions
92Shares Held
12.3MCall Options Held
164KPut Options Held
117K-
Israel Englander Millennium Management LLC | New York, Ny2.42MShares$6.02 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.25MShares$5.61 Million0.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il1.01MShares$2.52 Million0.0% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct780KShares$1.94 Million0.01% of portfolio
-
Alyeska Investment Group, L.P. Chicago, IL400KShares$996,0000.01% of portfolio
About CureVac N.V.
- Ticker CVAC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 187,467,008
- Market Cap $467M
- Description
- CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202, a prophylactic mRNA-based vaccine, which ...